Several studies have demonstrated that the rat isolated mediobasohypothalamus can release gonadotropin-releasing hormone (GnRH) in a pulsatile manner in vitro. We have now used an in vitro perifusion system to characterize GnRH release from the adult male Sprague-Dawley rat isolated median eminence (ME) alone. After 1 h stabilization periods, eight MEs released GnRH in an episodic pattern during 4-hour experiments (samples collected every 4 min, RIA in triplicate) with mean (± SE) release rates of 2.2 ± 0.2 pg GnRH/4 min and peak amplitudes of 1.3 ± 0.2 pg/4 min. The intervals between significant peaks were variable, although 70% were in the range of 12-24 min, i.e. similar to the non-gonadal steroid-modulated frequency of pulsatile luteinizing hormone secretion in gonadectomized rats in vivo. During nine additional experiments, MEs were perifused with control medium (containing 2.5 mM calcium) through the first hour of sample collection, then either calcium-free medium containing 0.5 mM of the calcium chelator EGTA and 100 µM of the intracellular calcium antagonist TMB-8 or calcium-free medium containing just 100 µM TMB-8 for 2 h, followed by a final hour with control medium. Removal of calcium activity decreased the frequency of GnRH peaks from 3.2 ± 0.3 to 1.3 ± 0.2/h, which then increased to 2.3 ± 0.3/h with subsequent replacement of control medium. Removal of available calcium also decreased mean GnRH release by 51 ± 11 %, which returned to basal levels with subsequent calcium replacement. These results suggest that either (1) the most fundamental unit of the GnRH pulse-generating mechanism is expressed even at the level of isolated ME axons and secretory terminals, or (2) the terminals of transected GnRH-secreting neurons may be inherently unstable and that there is some mechanism for coordination of pulses of GnRH release located within the ME at the level of the nerve terminals or axons.

Keywords:
Gonadotropin-releasing hormone, Pulsatile GnRH release, Median eminence, Perifusion, in vitro
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.